• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

sRAGE 与糖尿病、心血管疾病和死亡风险。

sRAGE and risk of diabetes, cardiovascular disease, and death.

机构信息

Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

出版信息

Diabetes. 2013 Jun;62(6):2116-21. doi: 10.2337/db12-1528. Epub 2013 Feb 8.

DOI:10.2337/db12-1528
PMID:23396398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3661610/
Abstract

Advanced glycation end products (AGEs) and their receptors are strongly implicated in the development of diabetes complications. When stimulated by AGEs, the receptors for AGEs (RAGEs) induce inflammation and are thought to fuel disease progression. Soluble circulating RAGE (sRAGE) may counteract the detrimental effects of RAGE. We measured sRAGE in stored plasma from a random sample of 1,201 participants in the Atherosclerosis Risk in Communities (ARIC) Study who were aged 47-68 years, had normal kidney function, and had no history of cardiovascular disease. In cross-sectional analyses, black race, male sex, higher BMI, and higher C-reactive protein were independently associated with low sRAGE. The racial difference was striking, with blacks approximately three times more likely to have low sRAGE compared with whites even after adjustment. During ~18 years of follow-up, there were 192 incident coronary heart disease events, 53 ischemic strokes, 213 deaths, and 253 cases of diabetes (among the 1,057 persons without diabetes at baseline). In multivariable Cox models comparing risk in the first quartile with that in the fourth quartile of baseline sRAGE, low levels of sRAGE were significantly associated with risk of diabetes (hazard ratio 1.64 [95% CI 1.10-2.44]), coronary heart disease (1.82 [1.17-2.84]), and mortality (1.72 [1.11-2.64]) but not ischemic stroke (0.78 [0.34-1.79]). In conclusion, we found that low levels of sRAGE were a marker of future chronic disease risk and mortality in the community and may represent an inflammatory state. Racial differences in sRAGE deserve further examination.

摘要

晚期糖基化终产物 (AGEs) 及其受体强烈参与糖尿病并发症的发展。当受到 AGEs 的刺激时,AGEs 的受体 (RAGEs) 会引发炎症,并被认为推动疾病的进展。可溶性循环 RAGE (sRAGE) 可能会抵消 RAGE 的有害影响。我们测量了来自随机抽取的 1201 名参加动脉粥样硬化风险社区研究(ARIC)的参与者的储存血浆中的 sRAGE,这些参与者年龄在 47-68 岁之间,肾功能正常,且没有心血管疾病史。在横断面分析中,黑种人、男性、更高的 BMI 和更高的 C 反应蛋白与低 sRAGE 独立相关。种族差异非常显著,即使在调整后,黑人患低 sRAGE 的可能性是白人的三倍左右。在大约 18 年的随访期间,有 192 例冠心病事件、53 例缺血性中风、213 例死亡和 253 例糖尿病(在基线时没有糖尿病的 1057 人中)。在比较基线 sRAGE 第一四分位数与第四四分位数风险的多变量 Cox 模型中,低水平的 sRAGE 与糖尿病(风险比 1.64 [95%CI 1.10-2.44])、冠心病(1.82 [1.17-2.84])和死亡率(1.72 [1.11-2.64])的风险显著相关,但与缺血性中风(0.78 [0.34-1.79])无关。总之,我们发现低水平的 sRAGE 是社区中未来慢性疾病风险和死亡率的标志物,可能代表一种炎症状态。sRAGE 的种族差异值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f966/3661610/d1ae1544efeb/2116fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f966/3661610/d1ae1544efeb/2116fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f966/3661610/d1ae1544efeb/2116fig1.jpg

相似文献

1
sRAGE and risk of diabetes, cardiovascular disease, and death.sRAGE 与糖尿病、心血管疾病和死亡风险。
Diabetes. 2013 Jun;62(6):2116-21. doi: 10.2337/db12-1528. Epub 2013 Feb 8.
2
sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.可溶性晚期糖基化终末产物受体、炎症与心房颤动风险:社区动脉粥样硬化风险(ARIC)研究结果
J Diabetes Complications. 2015 Mar;29(2):180-5. doi: 10.1016/j.jdiacomp.2014.11.008. Epub 2014 Nov 25.
3
Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.血浆可溶性晚期糖基化终产物受体(sRAGE)水平升高与 1 型糖尿病患者心血管疾病事件和全因死亡率相关:一项为期 12 年的随访研究。
Diabetes. 2010 Aug;59(8):2027-32. doi: 10.2337/db09-1509. Epub 2010 Jun 3.
4
Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.慢性肾脏病5期患者血浆S100A12和晚期糖基化终产物可溶性受体水平与死亡率
Nephrol Dial Transplant. 2015 Jan;30(1):84-91. doi: 10.1093/ndt/gfu259. Epub 2014 Jul 28.
5
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.晚期糖基化终末产物可溶性受体血浆水平与肾脏疾病风险的关联:社区动脉粥样硬化风险研究
Nephrol Dial Transplant. 2015 Jan;30(1):77-83. doi: 10.1093/ndt/gfu282. Epub 2014 Aug 21.
6
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.总可溶性及内源性晚期糖基化终产物受体作为 2 型糖尿病患者冠心病风险预测生物标志物的研究:来自 CARDS 试验的分析。
Diabetes. 2011 Sep;60(9):2379-85. doi: 10.2337/db11-0291. Epub 2011 Jul 19.
7
Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.中老年人群中晚期糖基化终产物可溶性受体循环水平的种族差异。
Metabolism. 2017 May;70:98-106. doi: 10.1016/j.metabol.2017.02.008. Epub 2017 Feb 10.
8
Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.可溶性晚期糖基化终产物受体与心血管疾病患者新发心血管事件的关系。
Atherosclerosis. 2017 Nov;266:234-239. doi: 10.1016/j.atherosclerosis.2017.08.015. Epub 2017 Aug 23.
9
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.可溶性晚期糖基化终产物受体(RAGE)是 1 型糖尿病患者全因和心血管死亡率的一个新的独立预测指标。
Diabetologia. 2011 Oct;54(10):2669-77. doi: 10.1007/s00125-011-2186-5. Epub 2011 May 24.
10
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.晚期糖基化终末产物受体内源性可溶性形式(sRAGE)在糖尿病中的动力学、作用及治疗意义
Curr Drug Targets. 2007 Oct;8(10):1138-43. doi: 10.2174/138945007782151298.

引用本文的文献

1
Exploring the Interplay Between Glycated Albumin, AGEs, and Inflammation in Old Patients with CKD.探索老年慢性肾脏病患者糖化白蛋白、晚期糖基化终末产物与炎症之间的相互作用
Metabolites. 2025 Aug 1;15(8):515. doi: 10.3390/metabo15080515.
2
The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.晚期糖基化终末产物(AGE)的AGE系统受体(RAGE):连接肥胖与心血管疾病的炎症途径。
Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707.
3
Weight-neutral early time-restricted eating improves glycemic variation and time in range without changes in inflammatory markers.

本文引用的文献

1
Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial.运动对 2 型糖尿病患者 sRAGE 水平和心血管代谢危险因素的影响:一项随机对照试验。
J Clin Endocrinol Metab. 2012 Oct;97(10):3751-8. doi: 10.1210/jc.2012-1951. Epub 2012 Jul 26.
2
Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden.可溶性晚期糖基化终产物受体水平与冠状动脉斑块负担呈负相关。
J Atheroscler Thromb. 2012;19(10):941-8. doi: 10.5551/jat.10561. Epub 2012 Jul 6.
3
Methodological and preanalytical evaluation of a RAGE immunoassay.
体重中性的早期限时进食可改善血糖变异性和血糖达标时间,而炎症标志物无变化。
iScience. 2024 Nov 29;27(12):111501. doi: 10.1016/j.isci.2024.111501. eCollection 2024 Dec 20.
4
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.晚期糖基化终产物受体 Gly82Ser 多态性增加了普通人群发生冠心病事件的风险。
Sci Rep. 2024 May 21;14(1):11567. doi: 10.1038/s41598-024-62385-5.
5
Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study.高迁移率族蛋白盒1和晚期糖基化终产物可溶性受体的血浆浓度是酒精使用障碍中认知障碍的相关生物标志物:一项初步研究。
Toxics. 2024 Feb 29;12(3):190. doi: 10.3390/toxics12030190.
6
Biomarkers of cellular senescence and risk of death in humans.细胞衰老的生物标志物与人类死亡风险。
Aging Cell. 2023 Dec;22(12):e14006. doi: 10.1111/acel.14006. Epub 2023 Oct 6.
7
Inflammatory proteins are associated with mortality in a middle-aged diverse cohort.炎症蛋白与中年人群的死亡率有关。
Clin Transl Med. 2023 Sep;13(9):e1412. doi: 10.1002/ctm2.1412.
8
Exploring Mechanisms of in Treating Ischemic Stroke with Network Pharmacology and Independent Cascade Model.网络药理学和独立级联模型探究 在治疗缺血性中风中的作用机制。
Comb Chem High Throughput Screen. 2024;27(7):959-968. doi: 10.2174/1386207326666230810094557.
9
Receptor for the Advanced Glycation End Products () Pathway in Adipose Tissue Metabolism.晚期糖基化终产物()途径在脂肪组织代谢中的受体。
Int J Mol Sci. 2023 Jul 1;24(13):10982. doi: 10.3390/ijms241310982.
10
Polymorphisms -374 T/A and -429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome.晚期糖基化终产物受体(RAGE)的-374 T/A和-429 T/C多态性以及RAGE血清水平(sRAGE)与代谢综合征无关。
Metabolites. 2023 Apr 5;13(4):521. doi: 10.3390/metabo13040521.
RAGE 免疫测定法的方法学和预分析评估。
Anticancer Res. 2012 May;32(5):2075-8.
4
Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension.可溶性晚期糖基化终产物受体水平与原发性高血压患者的蛋白尿和动脉僵硬度相关。
Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):382-8. doi: 10.1016/j.numecd.2011.10.003. Epub 2011 Dec 31.
5
Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.可溶性晚期糖基化终末产物受体(sRAGE)、内源性晚期糖基化终末产物受体(esRAGE)水平与血管炎症的关系:(18)F-氟脱氧葡萄糖正电子发射断层扫描分析。
Atherosclerosis. 2012 Feb;220(2):402-6. doi: 10.1016/j.atherosclerosis.2011.11.008. Epub 2011 Nov 16.
6
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.血浆中可溶性晚期糖基化终产物受体(sRAGE)和 RAGE 的促炎配体(EN-RAGE)水平与腹膜透析患者的颈动脉粥样硬化有关。
Atherosclerosis. 2012 Jan;220(1):208-14. doi: 10.1016/j.atherosclerosis.2011.07.115. Epub 2011 Aug 5.
7
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.总可溶性及内源性晚期糖基化终产物受体作为 2 型糖尿病患者冠心病风险预测生物标志物的研究:来自 CARDS 试验的分析。
Diabetes. 2011 Sep;60(9):2379-85. doi: 10.2337/db11-0291. Epub 2011 Jul 19.
8
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).血清晚期糖基化终产物可溶性受体与亚临床脑血管病的关系:北方曼哈顿研究(NOMAS)。
Atherosclerosis. 2011 May;216(1):192-8. doi: 10.1016/j.atherosclerosis.2011.01.024. Epub 2011 Jan 21.
9
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.血浆中晚期糖基化终产物水平升高与 1 型糖尿病患者心血管疾病事件和全因死亡率相关:一项 12 年随访研究。
Diabetes Care. 2011 Feb;34(2):442-7. doi: 10.2337/dc10-1087.
10
Advanced glycation end-products and the kidney.糖基化终产物与肾脏。
Eur J Clin Invest. 2010 Aug;40(8):742-55. doi: 10.1111/j.1365-2362.2010.02317.x.